A Study to Evaluate the Effect of Gabapentin on Cardiac Repolarization in Healthy Volunteers

Clinical trial NCT01516372 · COMPLETED

Trial details

NCT number: NCT01516372
Sponsor: XenoPort, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Restless Legs Syndrome

Start date: 2012-01-01
Primary completion: 2012-03-01
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.